147 results
Page 4 of 8
6-K
EX-99.1
1jn1gdrv8m fahytp
12 Nov 20
Current report (foreign)
6:15am
424B5
4utz2blh4a7q
23 Oct 20
Prospectus supplement for primary offering
4:40pm
6-K
EX-99.1
s0vgn1
20 Oct 20
Mereo BioPharma Appoints Christine Fox as Chief Financial Officer and Heidi Petersen as Senior Vice President, Regulatory Affairs
7:12am
6-K
EX-99.1
yz3f6j3tnpt9aulw0so
19 Oct 20
Current report (foreign)
8:10am
UPLOAD
fntncfnilrv
9 Oct 20
Letter from SEC
12:00am
6-K
EX-99.1
xq13bgba
7 Oct 20
Mereo BioPharma Files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission
9:53am
F-3
EX-1.2
80jmghd
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
plmiaa042silrf
6 Oct 20
Shelf registration (foreign)
4:25pm
F-6EF
EX-99
82cxs
6 Oct 20
Automatic registration for ADRs (foreign)
4:10pm
6-K
EX-99.1
nxxtgt7iujn2mqnmtngb
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.2
06n31pq8jh5ztgdq
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.1
mm9bi
28 Sep 20
Mereo BioPharma Announces Changes to Board of Directors
8:08am
6-K
EX-99.1
xyl1vezn75a
24 Sep 20
Mereo BioPharma Receives FDA Rare Pediatric Disease Designation for Setrusumab for the Treatment of Osteogenesis Imperfecta
8:48am
6-K
EX-99.1
hkr1dznp9wji99uo7
25 Aug 20
Mereo BioPharma Announces Initiation of Placebo-Controlled Phase 1b/2 Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
11:14am
UPLOAD
5yhs7yij4t37xokb
9 Jul 20
Letter from SEC
12:00am
F-3
tc7wbe6c5 ol8l45c
6 Jul 20
Shelf registration (foreign)
4:58pm
6-K
EX-99.3
6f73 4cta
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
eo6vj y5f7
16 Jun 20
Current report (foreign)
4:13pm